Meta-analysis-based preliminary exploration of the connection between ATDILI and schizophrenia by GSTM1/T1 gene polymorphisms

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Cai, Lei ^a   Cai, Mei Hong ^b   Wang, Mei Yan ^c   Xu, Yi Feng ^a   Chen, Wen Zhong ^a   Qin, Shen Ying ^a   Wan, Chun Ling ^a   He, Lin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c TONGJI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE T1; GLUTATHIONE TRANSFERASE; TUBERCULOSTATIC AGENT;

ADVERSE DRUG REACTION; ANTITUBERCULOSIS DRUG INDUCED LIVER INJURY; ARTICLE; CAUCASIAN; DATA EXTRACTION; DISEASE ASSOCIATION; DNA POLYMORPHISM; EAST ASIAN; EVIDENCE BASED MEDICINE; FACTUAL DATABASE; FIXED EFFECT MODEL; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GSTM1 GENE; GSTT1 GENE; HIGH RISK POPULATION; HUMAN; LIVER INJURY; MUTATIONAL ANALYSIS; PUBLISHING; RACE DIFFERENCE; RANDOM EFFECT MODEL; SAMPLE SIZE; SCHIZOPHRENIA; SENSITIVITY ANALYSIS; STATISTICAL MODEL; CHEMICAL AND DRUG INDUCED LIVER INJURY; GENETICS; META ANALYSIS; ODDS RATIO; PATHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; CHEMICAL AND DRUG INDUCED LIVER INJURY; DATABASES, FACTUAL; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; TUBERCULOSIS;

EID: 84934886672     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0128643     Document Type: Article

References (44)

1. WHO (2012) World Health Organization: Global tuberculosis report.
2. Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, et al. (2003) American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 167: 603-662. PMID: 12588714
3. Yee D, Valiquette C, Pelletier M, Parisien I, Rocher I, Menzies D (2003) Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. Am J Respir Crit Care Med 167: 1472-1477. PMID: 12569078
4. Thompson NP, Caplin ME, Hamilton MI, Gillespie SH, Clarke SW, Burroughs AK, et al. (1995) Anti-tuberculosis medication and the liver: dangers and recommendations in management. Eur Respir J 8: 1384-1388. PMID: 7489806
5. Nathwani RA, Kaplowitz N (2006) Drug hepatotoxicity. Clin Liver Dis 10: 207-217, vii. PMID: 16971258
6. Huang YS (2007) Genetic polymorphisms of drug-metabolizing enzymes and the susceptibility to antituberculosis drug-induced liver injury. Expert Opin Drug Metab Toxicol 3: 1-8. PMID: 17269890
7. Roy PD, Majumder M, Roy B (2008) Pharmacogenomics of anti-TB drugs-related hepatotoxicity. Pharmacogenomics 9: 311-321. doi: 10.2217/14622416.9.3.311 PMID: 18303967
8. Yew WW, Leung CC (2006) Antituberculosis drugs and hepatotoxicity. Respirology 11: 699-707. PMID: 17052297
9. Sullivan PF, Kendler KS, Neale MC (2003) Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 60: 1187-1192. PMID: 14662550
10. Saadat M, Mobayen F, Farrashbandi H (2007) Genetic polymorphism of glutathione S-transferase T1: a candidate genetic modifier of individual susceptibility to schizophrenia. Psychiatry Res 153: 87-91. PMID: 17586054
11. Yao JK, Reddy RD, van Kammen DP (2001) Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications. CNS Drugs 15: 287-310. PMID: 11463134
12. Valentini A, Gravina P, Bernardini S, Federici G (2008) Role of glutathione Stransferase in the cellular antioxidant defence. In: Eleuteri, A.M: Research Signpost, Kerala, India.
13. Harada S, Tachikawa H, Kawanishi Y (2001) Glutathione S-transferase M1 gene deletion may be associated with susceptibility to certain forms of schizophrenia. Biochem Biophys Res Commun 281: 267-271. PMID: 11181039
14. Gravina P, Spoletini I, Masini S, Valentini A, Vanni D, Paladini E, et al. (2011) Genetic polymorphisms of glutathione S-transferases GSTM1, GSTT1, GSTP1 and GSTA1 as risk factors for schizophrenia. Psychiatry Res 187: 454-456. doi: 10.1016/j.psychres.2010.10.008 PMID: 21093063
15. Sodhi CP, Rana SV, Mehta SK, Vaiphei K, Attri S, Thakur S, et al. (1996) Study of oxidative stress in isoniazid-induced hepatic injury in young rats with and without protein-energy malnutrition. J Biochem Toxicol 11: 139-146. PMID: 9029273
16. Pearson WR, Vorachek WR, Xu SJ, Berger R, Hart I, Vannais D, et al. (1993) Identification of class-mu glutathione transferase genes GSTM1-GSTM5 on human chromosome 1p13. Am J Hum Genet 53: 220-233. PMID: 8317488
17. Webb G, Vaska V, Coggan M, Board P (1996) Chromosomal localization of the gene for the human theta class glutathione transferase (GSTT1). Genomics 33: 121-123. PMID: 8617495
18. Kerb R, Brockmoller J, Sachse C, Roots I (1999) Detection of the GSTM1∗0 allele by long polymerase chain reaction. Pharmacogenetics 9: 89-94. PMID: 10208647
19. Huang RS, Chen P, Wisel S, Duan S, Zhang W, Cook EH, et al. (2009) Population-specific GSTM1 copy number variation. Hum Mol Genet 18: 366-372. doi: 10.1093/hmg/ddn345 PMID: 18948376
20. Sprenger R, Schlagenhaufer R, Kerb R, Bruhn C, Brockmoller J, Roots I, et al. (2000) Characterization of the glutathione S-transferase GSTT1 deletion: discrimination of all genotypes by polymerase chain reaction indicates a trimodular genotype-phenotype correlation. Pharmacogenetics 10: 557-565. PMID: 10975610
21. Roy B, Chowdhury A, Kundu S, Santra A, Dey B, Chakraborty M, et al. (2001) Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione S-transferase M1 'null' mutation. J Gastroenterol Hepatol 16: 1033-1037. PMID: 11595069
22. Teixeira RL, Morato RG, Cabello PH, Muniz LM, Moreira Ada S, Kritski AL, et al. (2011) Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients. Mem Inst Oswaldo Cruz 106: 716-724. PMID: 22012226
23. Watanabe Y, Nunokawa A, Kaneko N, Someya T (2010) A case-control study and meta-analysis of association between a common copy number variation of the glutathione S-transferase mu 1 (GSTM1) gene and schizophrenia. Schizophr Res 124: 236-237. doi: 10.1016/j.schres.2010.08.001 PMID: 20797839
24. Cai L, Deng SL, Liang L, Pan H, Zhou J, Wang MY, et al. (2013) Identification of genetic associations of SP110/MYBBP1A/RELA with pulmonary tuberculosis in the Chinese Han population. Hum Genet 132: 265-273. doi: 10.1007/s00439-012-1244-5 PMID: 23129390
25. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188. PMID: 3802833
26. Sutton A, Abrams KR, Jones DR, Sheldon TA, Song F (2000) Methods for meta-analysis in medical research: Wiley, Chichester.
27. Li C, Long J, Hu X, Zhou Y (2013) GSTM1 and GSTT1 genetic polymorphisms and risk of anti-tuberculosis drug-induced hepatotoxicity: an updated meta-analysis. Eur J Clin Microbiol Infect Dis 32: 859-868. doi: 10.1007/s10096-013-1831-y PMID: 23377313
28. Cochran W (1954) The combination of estimates from different experiments. Biometrics 10: 101-129.
29. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. Bmj 327: 557-560. PMID: 12958120
30. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. Bmj 315: 629-634. PMID: 9310563
31. Ioannidis JP, Boffetta P, Little J, O'Brien TR, Uitterlinden AG, Vineis P, et al. (2008) Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol 37: 120-132. PMID: 17898028
32. Harbord RM, Egger M, Sterne JA (2006) A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 25: 3443-3457. PMID: 16345038
33. Doherty AM, Kelly J, McDonald C, O'Dywer AM, Keane J, Cooney J (2013) A review of the interplay between tuberculosis and mental health. Gen Hosp Psychiatry 35: 398-406. doi: 10.1016/j.genhosppsych.2013.03.018 PMID: 23660587
34. Boyer TD (1989) The glutathione S-transferases: an update. Hepatology 9: 486-496. PMID: 2646197
35. Rowe JD, Nieves E, Listowsky I (1997) Subunit diversity and tissue distribution of human glutathione S-transferases: interpretations based on electrospray ionization-MS and peptide sequence-specific antisera. Biochem J 325 (Pt 2): 481-486. PMID: 9230131
36. Baez S, Segura-Aguilar J, Widersten M, Johansson AS, Mannervik B (1997) Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes. Biochem J 324 (Pt 1): 25-28. PMID: 9164836
37. Smythies J (1999) Redox mechanisms at the glutamate synapse and their significance: a review. Eur J Pharmacol 370: 1-7. PMID: 10323273
38. Juronen E, Tasa G, Uuskula M, Pooga M, Mikelsaar AV (1996) Purification, characterization and tissue distribution of human class theta glutathione S-transferase T1-1. Biochem Mol Biol Int 39: 21-29. PMID: 8799324
39. Landi S (2000) Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res 463: 247-283. PMID: 11018744
40. Petitti DB (1994) Meta-analysis, decision analysis and cost-effectiveness. New York, NY, USA: Oxford University Press.
41. Ioannidis JP, Ntzani EE, Trikalinos TA (2004) 'Racial' differences in genetic effects for complex diseases. Nat Genet 36: 1312-1318. PMID: 15543147
42. Cai Y, Yi J, Zhou C, Shen X (2012) Pharmacogenetic study of drug-metabolising enzyme polymorphisms on the risk of anti-tuberculosis drug-induced liver injury: a meta-analysis. PLoS One 7: e47769. doi: 10.1371/journal.pone.0047769 PMID: 23082213
43. Tang N, Deng R, Wang Y, Lin M, Li H, Qiu Y, et al. (2013) GSTM1 and GSTT1 null polymorphisms and susceptibility to anti-tuberculosis drug-induced liver injury: a meta-analysis. Int J Tuberc Lung Dis 17: 17-25. doi: 10.5588/ijtld.12.0447 PMID: 23232001
44. Kim SH, Kim SH, Yoon HJ, Shin DH, Park SS, Kim YS, et al. (2010) GSTT1 and GSTM1 null mutations and adverse reactions induced by antituberculosis drugs in Koreans. Tuberculosis (Edinb) 90: 39-43. doi: 10.1016/j.tube.2009.12.001 PMID: 20036620